It is possible new templates exist for this target since these models were created.
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
Crystal Structure of the Catalytic Domain of Coagulation Factor XI in Complex with Kunitz Protease … | Heteromer P03951; | 289-345 | 98.25 | |||
RELOCATING A NEGATIVE CHARGE IN THE BINDING POCKET OF TRYPSIN | Heteromer P00763; | 287-342 | 100 | |||
Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human… | Heteromer Q92876; | 289-343 | 100 | |||
Combinatorial Engineering of Proteolytically Resistant APPI Variants that Selectively Inhibit Human… | Heteromer Q92876; | 289-343 | 100 | |||
BOVINE TRYPSIN COMPLEXED TO APPI | Heteromer P00760; | 289-342 | 100 | 2×CA; | ||
BOVINE CHYMOTRYPSIN COMPLEXED TO APPI | Heteromer P00766; | 289-342 | 100 | |||
Human mesotrypsin complexed with amyloid precursor protein inhibitor(APPI) | Heteromer P35030; | 290-341 | 100 | 9×FMT; 1×CA; | ||
Structure of Human Mesotrypsin in complex with APPI variant T11V/M17R/I18F/F34V | Heteromer P35030; | 294-343 | 92.0 | 1×EDO; | ||
Human Mesotrypsin in complex with amyloid precursor protein inhibitor variant APPI-M17G/I18F/F34V | Heteromer P35030; | 294-342 | 93.88 | |||
Cryo-EM structure of the human formyl peptide receptor 2 in complex with Abeta42 and Gi2 | Heteromer P04899;P25090;P59768;P62873; | 672-713 | 100.0 | |||
Recognition of the Amyloid Precursor Protein by Human gamma-secretase | Heteromer P49768;Q92542;Q96BI3;Q9NZ42; | 688-726 | 100.0 | 5×NAG; 1×NAG; 6×NAG; 2×PC1; 3×CLR; | ||
Crystal structure of the intracellular domain of human APP in complex with Fe65-PTB2 | Heteromer O00213; | 741-768 | 100 | |||
Crystal structure of the intracellular domain of human APP (T668A mutant) in complex with Fe65-PTB2 | Heteromer O00213; | 742-768 | 96.3 | |||
Crystal structure of the intracellular domain of human APP (T668E mutant) in complex with Fe65-PTB2 | Heteromer O00213; | 742-768 | 96.3 | |||
Cryo-EM structure of human gamma-secretase in complex with APP-C99 | Heteromer P49768;Q92542;Q96BI3;Q9NZ42; | 702-726 | 96.0 | 5×NAG; 1×NAG; 6×NAG; 3×PC1; 3×CLR; | ||
Structure of Alzheimer Ab peptide in complex with an engineered binding protein | Heteromer | 687-711 | 100 | |||
Crystal structure of human insulin-degrading enzyme in complex with amyloid-beta (1-40) | Heteromer P14735; | 672-694 | 100.0 | 1×DIO; | ||
Crystal structure of human insulin-degrading enzyme in complex with amyloid-beta (1-42) | Heteromer P14735; | 672-693 | 100.0 | 1×ZN; | ||
Cryo-EM structure of human gamma-secretase in complex with Abeta49 | Heteromer P49768;Q92542;Q96BI3;Q9NZ42; | 699-720 | 95.45 | 5×NAG; 1×NAG; 6×NAG; 2×PC1; 2×CLR; | ||
Cryo-EM structure of human gamma-secretase in complex with Abeta46 | Heteromer P49768;Q92542;Q96BI3;Q9NZ42; | 696-717 | 100 | 5×NAG; 1×NAG; 6×NAG; 3×PC1; 2×CLR; | ||
Crystal Structure Analysis of Fab-Bound Human Insulin Degrading Enzyme (IDE) in Complex with Amyloi… | Heteromer P14735; | 672-691 | 100.0 | 1×ZN; | ||
ANTIBODY C706 IN COMPLEX WTH BETA-AMYLOID PEPTIDE 1-16 | Heteromer | 672-687 | 100 | 4×SO4; 3×GOL; | ||
Fab-amyloid beta fragment complex at neutral pH | Heteromer | 686-700 | 86.67 | 1×CL; 1×NA; | ||
Crystal Structure of TAP01 in complex with cyclised amyloid beta peptide | Heteromer | 672-685 | 85.71 | 1×EDO; 1×ZN; | ||
Fab-amyloid beta fragment complex | Heteromer | 686-699 | 85.71 | 3×EDO; 2×PEG; | ||
Crystal structure of APP peptide bound rat Mint2 PARM | Heteromer O35431; | 754-767 | 100 | |||
Crystal structure of an engineered lipocalin (Anticalin US7) in complex with the Alzheimer amyloid … | Heteromer P80188; | 687-699 | 100 | |||
X11 PTB DOMAIN | Heteromer Q02410; | 754-766 | 100 | |||
Structure of Pyroglutamate-Abeta-specific Fab c#24 in complex with human Abeta-pE3-18 | Heteromer | 674-685 | 91.67 | |||
Crystal Structure of the GULP1 PTB domain-APP peptide complex | Heteromer Q9UBP9; | 755-766 | 100 | 2×SO4; 1×EDO; | ||
Crystal structure of crenezumab Fab in complex with Abeta | Heteromer P0DOX5;Q0KKI6; | 684-695 | 100 | |||
CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11 | Heteromer | 672-682 | 100 | 1×NAG; 1×SO4; | ||
Crystal structure of an engineered lipocalin (Anticalin H1GA) in complex with the Alzheimer amyloid… | Heteromer P80188; | 688-698 | 100 | |||
Crystal Structure of mid-region amyloid beta capture by solanezumab | Heteromer P01834;P01857; | 687-697 | 100 | |||
Fab-antibody complex | Heteromer | 701-711 | 100 | |||
24B3 antibody-peptide complex | Heteromer | 687-697 | 90.91 | |||
Crystal Structure of TAP01 in complex with amyloid beta peptide | Heteromer | 674-683 | 90.0 | 1×FLC; | ||
Structure of Pyroglutamate-Abeta-specific Fab c#6 in complex with human Abeta-pE3-12-PEGb | Heteromer | 674-683 | 90.0 | 1×SO4; 2×GOL; | ||
Crystal structure of MMP-2 active site mutant in complex with APP-drived decapeptide inhibitor | Heteromer P08253; | 586-595 | 100 | 2×ZN; 3×CA; | ||
Crystal Structure of Human Presequence Protease in Complex with Amyloid-beta (1-40) | Heteromer Q5JRX3; | 686-694 | 100 | 1×ZN; 1×GOL; 2×ACT; | ||
Design of a split green fluorescent protein for sensing and tracking an beta-amyloid | Heteromer | 685-693 | 100 | |||
Crystal structure of the complex formed between Phospholipase A2 with beta-amyloid fragment, Lys-Gl… | Heteromer P60045; | 699-706 | 100 | 1×CA; | ||
Phospholipase A2 Prevents the Aggregation of Amyloid Beta Peptides: Crystal Structure of the Comple… | Heteromer P60045; | 672-679 | 100 | 1×CA; | ||
X-ray structure of amyloid beta peptide:antibody (Abeta1-7:12A11) complex | Heteromer | 672-678 | 100 | |||
Crystal structure of Fab wo2 bound to the n terminal domain of amyloid beta peptide (1-16) | Heteromer A2NHM3;P84751; | 673-679 | 100 | |||
Crystal structure of Fab WO2 bound to the N terminal domain of Amyloid beta peptide (1-28) | Heteromer A2NHM3;Q811U5; | 673-679 | 100 | |||
Crystal structure of adaptor protein complex 4 (AP-4) mu4 subunit C-terminal domain, in complex wit… | Heteromer O00189; | 761-767 | 100 | 3×GOL; | ||
PFA1 Fab fragment complexed with Abeta 1-8 peptide | Heteromer A2NHM3; | 673-679 | 100 | 2×ACM; 3×GOL; | ||
Cereblon isoform 4 from Magnetospirillum gryphiswaldense in complex a long aspartimide degron pepti… | Heteromer A4TVL0; | 764-770 | 100 | 1×ZN; | ||
Crystal structure of adaptor protein complex 4 (AP-4) mu4 subunit C-terminal domain D190A mutant, i… | Heteromer O00189; | 761-767 | 100 | |||
Structures of Grb2-SH2 Domain and AICD peptide Complexes Reveal a Conformational Switch and Their F… | Heteromer P62993; | 756-762 | 100 | |||
Crystal Structure of the Complex Formed Between a New Isoform of Phospholipase A2 with C-terminal A… | Heteromer P60045; | 707-713 | 100 | 1×CA; | ||
Structures of Grb2-SH2 Domain and AICD peptide Complexes Reveal a Conformational Switch and Their F… | Heteromer P62993; | 756-762 | 85.71 | |||
Crystal Structure of the VAV2 SH2 domain in complex with APP phosphorylated peptide | Heteromer P52735; | 755-761 | 100 | |||
PFA2 FAB complexed with Abeta1-8 | Heteromer A2NHM3;Q811U5; | 673-679 | 100 | 1×NA; | ||
Crystal Structure of the Complex Formed Between Phospholipase A2 and a Hexapeptide Fragment of Amyl… | Heteromer P60045; | 687-692 | 100 | 1×CA; | ||
Crystal structure of an engineered lipocalin (Anticalin US7) in complex with the Alzheimer amyloid … | Heteromer P80188; | 689-694 | 100 | |||
X-ray structure of amyloid beta peptide:antibody (Abeta1-40:12A11) complex | Heteromer | 673-678 | 100 | |||
Humanised 3D6 Fab complexed to amyloid beta 1-8 | Heteromer | 672-677 | 100 | |||
Fab fragment of 3D6 in complex with amyloid beta 1-7 | Heteromer | 672-677 | 100 | |||
X-ray structure of amyloid beta peptide:antibody (Abeta1-7:10D5) complex | Heteromer | 673-678 | 100 | |||
Crystal structure of a humanised 3D6 Fab bound to amyloid beta peptide | Heteromer P01834;P01857; | 672-677 | 100 | |||
Structure of Pyroglutamate-Abeta-specific Fab c#17 in complex with human Abeta-pE3-12PEGb | Heteromer | 674-679 | 83.33 | |||
aducanumab abeta complex | Heteromer | 673-678 | 100 | 1×SO4; | ||
X-ray structure of amyloid beta peptide:antibody (Abeta1-7:12B4) complex | Heteromer | 673-678 | 100 | |||
Alzheimer's Amyloid-Beta Peptide Fragment 29-40 in Complex with Cd-substituted Thermolysin | Heteromer P43133; | 700-704 | 100 | 1×CA; 4×CD; 1×DMS; | ||
Alzheimer's Amyloid-Beta Peptide Fragment 1-40 in Complex with Cd-substituted Thermolysin | Heteromer P43133; | 700-704 | 100 | 3×CA; 2×CD; 1×DMS; | ||
Fab fragment of 3D6 in complex with amyloid beta 1-40 | Heteromer | 672-676 | 100 | 27×ZN; 3×IMD; 11×CL; | ||
Alzheimer's Amyloid-Beta Peptide Fragment 1-40 in Complex with Thermolysin | Heteromer P00800; | 702-704 | 100 | 4×CA; 1×ZN; 1×DMS; | ||
Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 4-10 | Heteromer P12821; | 678-680 | 100 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 1×SO4; 4×PEG; | ||
Structure of Human Neurolysin (E475Q) in complex with amyloid-beta 35-40 peptide product | Heteromer Q9BYT8; | 709-711 | 100 | 1×ZN; 1×CL; | ||
CryoEM structure of human presequence protease in partial closed state 1 | Heteromer Q5JRX3; | 690-692 | 100 | |||
Crystal structure of the Angiotensin-1 converting enzyme N-domain in complex with amyloid-beta 35-42 | Heteromer P12821; | 712-713 | 100 | 1×NAG; 1×NAG; 1×NAG; 1×ZN; 1×CL; 3×PEG; 1×PG4; 1×P6G; | ||
J-shaped conformer of amyloid beta (1-40) | homo-40-mer | 672-711 | 100 | |||
Atomic model of the Abeta D23N "Iowa" mutant using solid-state NMR, EM and Rosetta modeling | homo-27-mer | 686-711 | 96.15 | |||
Type IIIb beta-amyloid 40 Filaments from Down Syndrome | homo-20-mer | 672-711 | 100 | |||
Amyloid-beta 40 type 2 filament from the leptomeninges of individual with Alzheimer's disease and c… | homo-20-mer | 672-709 | 100 | |||
Type Id amyloid-beta 42 filaments in dominantly inherited Alzheimer disease with cotton wool plaques | homo-20-mer | 680-713 | 100 | |||
Type Ic amyloid-beta 42 filaments in dominantly inherited Alzheimer disease with cotton wool plaques | homo-20-mer | 680-713 | 100 | |||
Structural Model for a 40-residue Beta-Amyloid Fibril with Three-Fold Symmetry, Negative Stagger | homo-18-mer | 680-711 | 100 | |||
Structural Model for a 40-residue Beta-Amyloid Fibril with Three-Fold Symmetry, Positive Stagger | homo-18-mer | 680-711 | 100 | |||
Atomic Resolution Structure of Monomorphic AB42 Amyloid Fibrils | homo-18-mer | 682-713 | 100 | |||
Mixing Abeta(1-40) and Abeta(1-42) peptides generates unique amyloid fibrils | homo-16-mer | 682-713 | 100 | |||
Mixing Abeta(1-40) and Abeta(1-42) peptides generates unique amyloid fibrils | homo-16-mer | 682-713 | 100 | |||
A New Structural Model of Abeta(1-40) Fibrils | homo-16-mer | 682-711 | 100 | |||
Abeta fibril (Morphology I) | homo-12-mer | 672-711 | 100 | |||
seeded Abeta(1-40) amyloid fibril (morphology I) | homo-12-mer | 672-708 | 100 | |||
The cryo-EM structure of AV-45 bound type1 amyloid beta 42 fibril. | homo-12-mer | 680-713 | 100 | 2×VW6; | ||
Structural Model for a 40-Residue Beta-Amyloid Fibril with Two-Fold Symmetry, Negative Stagger | homo-12-mer | 680-711 | 100 | |||
42-Residue Beta Amyloid Fibril | homo-12-mer | 682-713 | 100 | |||
Structural Model for a 40-Residue Beta-Amyloid Fibril with Two-Fold Symmetry, Positive Stagger | homo-12-mer | 680-711 | 100 | |||
Amyloid-beta tetrameric filaments with the Arctic mutation (E22G) from Alzheimer's disease brains |… | homo-12-mer | 682-711 | 96.3 | |||
unseeded Abeta(1-40) amyloid fibril (morphology ii) | homo-12-mer | 684-711 | 100 | |||
unseeded Abeta(1-40) amyloid fibril (morphology i) | homo-12-mer | 684-711 | 100 | |||
Covalently stabilized triangular trimer composed of Abeta17-36 beta-hairpins | homo-12-mer | 687-707 | 80.95 | |||
Triangular trimer of beta-hairpins derived from Abeta17-36 with an F20Cha mutation | homo-12-mer | 686-706 | 71.43 | |||
X-ray crystallographic structure of an Abeta 17-36 beta-hairpin. LV(PHI)FAEDCGSNKCAII(SAR)L(ORN)V | homo-12-mer | 688-707 | 85.0 | |||
X-ray crystallographic structure of an A-beta 17_36 beta-hairpin. X-ray diffractometer data set. (L… | homo-12-mer | 688-707 | 90.0 | 2×JEF; | ||
Amyloid Beta KLVFFAENVGS 16-26 D23N Iowa mutation | homo-12-mer | 687-697 | 90.91 | |||
Structure of an amyloid forming peptide GAIIGL (29-34) from amyloid beta | homo-12-mer | 700-705 | 100 | |||
Structure of an amyloid forming peptide KLVFFA from amyloid beta, alternate polymorph II | homo-12-mer | 687-692 | 100 | |||
Atomic-resolution 3D structure of amyloid-beta fibrils: the Osaka mutation | homo-10-mer | 672-711 | 100 | |||
Lipidic amyloid-beta(1-40) fibril - polymorph L1 | homo-10-mer | 672-711 | 100 | |||
Lipidic amyloid-beta(1-40) fibril - polymorph L3-L3 | homo-10-mer | 672-711 | 100 | |||
S8 phosphorylated beta amyloid 40 fibrils | homo-10-mer | 672-711 | 100 | 10×2PO; | ||
Lipidic amyloid-beta(1-40) fibril - polymorph L2-L3 | homo-10-mer | 672-711 | 100 | |||
Sarkosyl-extracted AppNL-G-F Abeta42 fibril structure | homo-10-mer | 672-709 | 97.37 | |||
Sarkosyl-extracted AppNL-G-F Abeta42 fibril structure (Methoxy-X04-labelled mice) | homo-10-mer | 672-709 | 97.37 | |||
Amyloid-beta (1-40) fibrils derived from a CAA patient | homo-10-mer | 672-709 | 100 | |||
DI1 Abeta fibril from tg-SwDI mouse | homo-10-mer | 672-707 | 94.44 | |||
Lipidic amyloid-beta(1-40) fibril - polymorph L2-L2 | homo-10-mer | 676-711 | 100 | |||
Type I beta-amyloid 42 Filaments from Human Brain | homo-10-mer | 680-713 | 100 | 10×UNX; | ||
Type I beta-amyloid 42 Filaments from Down syndrome | homo-10-mer | 680-713 | 100 | |||
Murine type III Abeta fibril from APP/PS1 mouse | homo-10-mer | 681-713 | 100 | |||
MurineArc type I Abeta fibril from tg-APPArcSwe mouse | homo-10-mer | 680-711 | 96.88 | |||
Type IIIa beta-amyloid 40 Filaments from Down syndrome | homo-10-mer | 680-711 | 100 | |||
Murine type III Abeta fibril from ARTE10 mouse | homo-10-mer | 681-711 | 100 | |||
Murine type II Abeta fibril from ARTE10 mouse | homo-10-mer | 683-713 | 100 | |||
Murine type II Abeta fibril from tgAPPSwe mouse | homo-10-mer | 683-713 | 100 | |||
Murine type II Abeta fibril from APP23 mouse | homo-10-mer | 683-713 | 100 | |||
Type II beta-amyloid 42 Filaments from Human Brain | homo-10-mer | 683-713 | 100 | 10×UNX; | ||
Amyloid-Beta (20-34) with L-isoaspartate 23 | homo-10-mer | 691-705 | 100 | |||
VGSNKGAIIGL from Amyloid Beta determined by MicroED | homo-10-mer | 695-705 | 100 | |||
Near-atomic resolution fibril structure of complete amyloid-beta(1-42) by cryo-EM | homo-9-mer | 672-713 | 100 | |||
40-residue beta-amyloid fibril derived from Alzheimer's disease brain | homo-9-mer | 672-711 | 100 | |||
The cryo-EM structure of AV-45 bound type3 amyloid beta 42 fibril. | homo-9-mer | 680-713 | 100 | |||
The cryo-EM structure of type3 amyloid beta 42 fibril. | homo-9-mer | 680-713 | 100 | |||
Brain-derived 42-residue amyloid-beta fibril type B | homo-8-mer | 672-713 | 100 | |||
Brain-derived 42-residue amyloid-beta fibril type A | homo-8-mer | 683-713 | 100 | |||
Amyloid-beta assemblage on GM1-containing membranes | homo-8-mer | 683-711 | 100 | |||
40-residue D23N beta amyloid fibril | homo-8-mer | 686-711 | 96.15 | |||
X-ray crystallographic structure of a beta-hairpin peptide derived from amyloid beta 16-36 | homo-8-mer | 685-706 | 81.82 | 7×HEZ; | ||
Structure of amyloid-beta derived peptide - NKGAIF | homo-8-mer | 698-703 | 83.33 | 8×PO4; | ||
Amyloid beta oligomer displayed on the alpha hemolysin scaffold | homo-7-mer | 672-713 | 100 | |||
Atomic resolution structure of a disease-relevant Abeta(1-42) amyloid fibril | homo-6-mer | 672-713 | 100 | |||
Cryo-EM structure of the fibril formed by disaccharide-modified amyloid-beta(1-42) | homo-6-mer | 677-713 | 100 | 6×X6X; 6×ACY; | ||
The cryo-EM structure of type1 amyloid beta 42 fibril. | homo-6-mer | 680-713 | 100 | |||
The cryo-EM structure of type1 amyloid beta 42 fibril in AD3. | homo-6-mer | 680-713 | 100 | |||
The cryo-EM structure of type1 amyloid beta 42 fibril in AD2 patient. | homo-6-mer | 680-713 | 100 | |||
Type I amyloid-beta 42 filaments from high-spin supernatants of aqueous extracts from Alzheimer's d… | homo-6-mer | 680-713 | 100 | |||
Ab typeII filament from Guam ALS/PDC | homo-6-mer | 683-713 | 100 | |||
Amyloid-beta(1-40) fibril derived from Alzheimer's disease cortical tissue | homo-6-mer | 681-711 | 100 | |||
Amyloid-beta 42 filaments extracted from the human brain with Arctic mutation (E22G) of Alzheimer's… | homo-6-mer | 683-713 | 96.77 | |||
Type II amyloid-beta 42 filaments from high-spin supernatants of aqueous extracts from Alzheimer's … | homo-6-mer | 683-713 | 100 | |||
Amyloid-beta (1-40) fibrils derived from familial Dutch-type CAA patient (population B) | homo-6-mer | 686-710 | 100 | |||
Racemic mixture of amyloid beta segment 35-MVGGVV-40 forms heterochiral rippled beta-sheet, include… | homo-6-mer | 706-711 | 100 | 6×YWK; | ||
Structure of an amyloid forming peptide NKGAII (residues 27-32) from amyloid beta | homo-6-mer | 698-703 | 100 | |||
Racemic mixture of amyloid beta segment 16-KLVFFA-21 forms heterochiral rippled beta-sheet | homo-6-mer | 687-692 | 100 | 6×TFA; | ||
Lipidic amyloid-beta(1-40) fibril - polymorph L3 | homo-5-mer | 672-711 | 100 | |||
DI2 Abeta fibril from tg-SwDI mouse | homo-5-mer | 672-710 | 94.87 | |||
Lipidic amyloid-beta(1-40) fibril - polymorph L2 | homo-5-mer | 676-711 | 100 | |||
DI3 Abeta fibril from tg-SwDI mouse | homo-5-mer | 673-704 | 93.75 | |||
3D Structure of Alzheimer's Abeta(1-42) fibrils | homo-5-mer | 688-713 | 100 | |||
Amyloid-Beta (20-34) wild type | homo-5-mer | 691-705 | 100 | |||
Structure of pore-forming amyloid-beta tetramers | homo-4-mer | 672-713 | 100 | |||
Structure of segment MVGGVVIA from the amyloid-beta peptide (Ab, residues 35-42), alternate polymor… | homo-4-mer | 706-713 | 100 | |||
Structure of an amyloid forming peptide KLVFFA from amyloid beta in complex with orange G | homo-4-mer | 687-692 | 100 | 2×ORA; | ||
Structure of segment AIIGLM from the amyloid-beta peptide (Ab, residues 30-35) | homo-4-mer | 701-706 | 100 | |||
X-ray crystallographic structure of an A-beta 17_36 beta-hairpin. Synchrotron data set. (LVFFAEDCGS… | homo-3-mer | 688-707 | 90.0 | |||
A receptor molecule | homo-2-mer | 385-624 | 100 | 1×SGN; 6×ZN; 1×CA; 3×GOL; 1×ACT; 3×SCN; 1×SO4; 1×MG; | ||
The X-ray structure of an antiparallel dimer of the human amyloid precursor protein E2 domain | homo-2-mer | 371-566 | 100 | |||
Crystal Structure Analysis of APP E2 domain | homo-2-mer | 379-559 | 100 | 2×OS; | ||
Structure of the Heparin-induced E1-Dimer of the Amyloid Precursor Protein (APP) | homo-2-mer | 26-190 | 100 | 2×BU4; 1×SO4; 1×ACT; | ||
X-RAY CRYSTAL STRUCTURE OF THE PROTEASE INHIBITOR DOMAIN OF ALZHEIMER'S AMYLOID BETA-PROTEIN PRECUR… | homo-2-mer | 287-342 | 100 | |||
Dimeric structure of transmembrane domain of amyloid precursor protein in micellar environment | homo-2-mer | 686-726 | 100 | |||
X-ray crystallographic structure of a beta-hairpin peptide derived from amyloid beta 14-40 | homo-2-mer | 682-711 | 83.33 | 1×CL; | ||
Solution NMR structure of transmembrane domain of amyloid precursor protein WT | homo-2-mer | 699-726 | 100 | |||
Solution NMR structure of transmembrane domain of amyloid precursor protein V44M | homo-2-mer | 699-726 | 96.43 | |||
Electron cryo-microscopy of an Abeta(1-42)amyloid fibril | homo-2-mer | 686-713 | 100 | |||
Beta hairpin derived from Abeta17-36 with an F20Cha mutation | homo-2-mer | 686-706 | 80.95 | 2×CL; 1×NA; | ||
Zinc induced dimer of the metal binding domain 1-16 of human amyloid beta-peptide with Alzheimer's … | homo-2-mer | 672-687 | 93.75 | 1×ZN; | ||
Zinc bound dimer of the fragment of human amyloid-beta peptide with Alzheimer's disease pathogenic … | homo-2-mer | 672-681 | 90.0 | 2×ZN; | ||
Structure of segment MVGGVVIA from the amyloid-beta peptide (Ab, residues 35-42), alternate polymor… | homo-2-mer | 706-713 | 100 | |||
X-ray structure of the E2 domain of the human amyloid precursor protein (APP) in complex with copper | monomer | 384-567 | 100 | 1×ACT; 2×CU; 7×CD; | ||
X-ray structure of the E2 domain of the human amyloid precursor protein (APP) in complex with zinc | monomer | 385-567 | 100 | 1×ACT; 1×ZN; 8×CD; | ||
X-ray structure of the E2 domain of the human amyloid precursor protein (APP) in complex with cadmi… | monomer | 388-567 | 100 | 2×ACT; 9×CD; | ||
HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE E1-DOMAIN of THE AMYLOID PRECURSOR PROTEIN | monomer | 28-189 | 100 | |||
Solution structure of CAPPD*, an independently folded extracellular domain of human Amyloid-beta Pr… | monomer | 460-569 | 100 | |||
The longer crystal structure of the grow factor like domain from Beta amypoid precusor protein (APP… | monomer | 22-126 | 100 | |||
Crystal structure of the N-terminal, growth factor-like domain of the amyloid precursor protein bou… | monomer | 23-123 | 100 | 1×CU; 1×GOL; | ||
N-TERMINAL DOMAIN OF THE AMYLOID PRECURSOR PROTEIN | monomer | 28-123 | 100 | |||
Structure of the Alzheimer's disease amyloid precursor protein copper binding domain | monomer | 124-189 | 100 | |||
Structure of the Alzheimer's Amyloid Precursor Protein (APP) Copper Binding Domain (Residues 126- 1… | monomer | 126-189 | 100 | |||
Structure of the Alzheimer's Amyloid Precursor Protein (APP) Copper Binding Domain in 'small unit c… | monomer | 133-189 | 100 | 1×GOL; | ||
Structure of the Alzheimer's Amyloid Precursor Protein (APP) Copper Binding Domain in 'small unit c… | monomer | 133-189 | 100 | 1×CU; | ||
Structure of the Alzheimer's Amyloid Precursor Protein (APP) copper binding domain (residues 133 to… | monomer | 133-189 | 100 | |||
Structure of the Alzheimer's Amyloid Precursor Protein (APP) Copper Binding Domain in 'small unit c… | monomer | 133-189 | 100 | 1×CU1; | ||
Structure of the Alzheimer's Amyloid Precursor Protein (APP) Copper Binding Domain in 'large unit c… | monomer | 133-189 | 100 | 4×CU; | ||
Dynamic complex between all-D-enantiomeric peptide D3 with wild-type amyloid precursor protein 672-… | monomer | 672-726 | 100 | |||
Dynamic complex between all-D-enantiomeric peptide D3 with L723P mutant of amyloid precursor protei… | monomer | 672-726 | 98.18 | |||
The solution NMR structure of the transmembrane C-terminal domain of the amyloid precursor protein … | monomer | 683-728 | 100 | |||
Aqueous Solution Structure of the Alzheimer's Disease Abeta Peptide (1-42) | monomer | 672-713 | 100 | |||
Solution structure of the Alzheimer's disease amyloid beta-peptide (1-42) | monomer | 672-713 | 100 | |||
Solution structure of the amyloid beta-peptide (1-42) | monomer | 672-713 | 100 | |||
Structure of amyloid precursor protein's transmembrane domain | monomer | 686-726 | 100 | |||
THE SOLUTION STRUCTURE OF AMYLOID BETA-PEPTIDE (1-40) IN A WATER-MICELLE ENVIRONMENT. IS THE MEMBRA… | monomer | 672-711 | 100 | |||
3D NMR structure of a complex between the amyloid beta peptide (1-40) and the polyphenol epsilon-vi… | monomer | 672-711 | 100 | 2×23Y; | ||
SOLUTION STRUCTURE OF THE METHIONINE-OXIDIZED AMYLOID BETA-PEPTIDE (1-40). DOES OXIDATION AFFECT CO… | monomer | 672-711 | 100 | |||
A partially folded structure of amyloid-beta(1 40) in an aqueous environment | monomer | 672-711 | 100 | |||
3D NMR structure of a complex between the amyloid beta peptide (1-40) and the polyphenol epsilon-vi… | monomer | 672-711 | 100 | 2×23Y; | ||
THE ALZHEIMER`S DISEASE AMYLOID A4 PEPTIDE (RESIDUES 1-40) | monomer | 672-711 | 100 | |||
Amyloid-beta 40 type 1 filament from the leptomeninges of individual with Alzheimer's disease and c… | monomer | 672-709 | 100 | |||
Solution NMR Structure of APP V44M mutant TMD | monomer | 697-726 | 96.67 | |||
Solution NMR Structure of APP I45T mutant TMD | monomer | 697-726 | 96.67 | |||
Solution NMR Structure of APP G38L mutant TMD | monomer | 697-726 | 96.67 | |||
Solution NMR Structure of APP G38P mutant TM | monomer | 697-726 | 96.67 | |||
Solution NMR Structure of APP TMD | monomer | 697-726 | 100 | |||
SOLUTION NMR STRUCTURE OF AMYLOID BETA[E16], RESIDUES 1-28, 14 STRUCTURES | monomer | 672-699 | 96.43 | |||
SOLUTION NMR STRUCTURE OF AMYLOID BETA[F16], RESIDUES 1-28, 15 STRUCTURES | monomer | 672-699 | 96.43 | |||
SOLUTION STRUCTURE OF RESIDUES 1-28 OF THE AMYLOID BETA-PEPTIDE | monomer | 672-699 | 100 | |||
SOLUTION STRUCTURE OF RESIDUES 1-28 OF THE AMYLOID BETA-PEPTIDE | monomer | 672-699 | 100 | |||
ALZHEIMER'S DISEASE AMYLOID-BETA PEPTIDE (RESIDUES 10-35) | monomer | 681-706 | 100 | |||
Amyloid beta(18-41) peptide fusion with new antigen receptor variable domain from sharks | monomer | 689-712 | 100 | |||
Molecular structure of Cu(II)-bound amyloid-beta monomer implicated in inhibition of peptide self-a… | monomer | 672-694 | 100 | 1×CU; | ||
Molecular structure of Cu(II)-bound amyloid-beta monomer implicated in inhibition of peptide self-a… | monomer | 672-694 | 100 | 1×CU; | ||
NMR structure of the soluble A beta 17-34 peptide | monomer | 688-705 | 100 | |||
Zinc-binding domain of Alzheimer's disease amyloid beta-peptide in water solution at pH 6.5 | monomer | 672-687 | 100 | |||
Zinc-binding domain of Alzheimer's disease amyloid beta-peptide in TFE-water (80-20) solution | monomer | 672-687 | 100 | |||
Zinc-binding domain of Alzheimer's disease amyloid beta-peptide complexed with a zinc (II) cation | monomer | 672-687 | 100 | 1×ZN; | ||
NMR analysis of 25-35 fragment of beta amyloid peptide | monomer | 696-706 | 100 | |||
NMR structure of the fragment 25-35 of beta amyloid peptide in 20/80 v:v hexafluoroisopropanol/wate… | monomer | 696-706 | 100 | |||
Solution structure of fragment (25-35) of beta amyloid peptide in SDS micellar solution | monomer | 696-706 | 100 | |||
AMYLOID BETA PEPTIDE (25-35), NMR, 20 STRUCTURES | monomer | 696-706 | 100 | |||
Structure of segment KLVFFA from the amyloid-beta peptide (Ab, residues 16-21), alternate polymorph… | monomer | 687-692 | 100 | 1×ACT; | ||
Structure of segment KLVFFA from the amyloid-beta peptide (Ab, residues 16-21), alternate polymorph… | monomer | 687-692 | 100 | |||
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7mrm.1.A | monomer | 0.74 | 30-189 | 93.57 | ||
6har.1.B | monomer | 0.62 | 294-342 | 90.57 | ||
2ysz.1.A | monomer | 0.53 | 733-770 | 84.21 | ||
Model ID | Oligo-state | Avg pLDDT | Range | Trg-Mdl Seq Id (%) |
---|
Model ID | Oligo-state | Avg Confidence | Range | Trg-Mdl Seq id (%) |
---|
Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|---|
Isoform 2 | 3ktm.1.B | monomer | 0.75 | 26-190 | 1×BU4; | 100.00 | |
Isoform 3 | 7mrm.1.A | monomer | 0.73 | 30-189 | 93.57 | ||
Isoform 3 | 2ysz.1.A | monomer | 0.60 | 640-677 | 84.21 | ||
Isoform 4 | 7mrm.1.A | monomer | 0.72 | 30-189 | 93.57 | ||
Isoform 4 | 2ysz.1.A | monomer | 0.56 | 658-695 | 84.21 | ||
Isoform 5 | 5tpt.1.A | monomer | 0.72 | 318-514 | 67.51 | ||
Isoform 5 | 7mrm.1.A | monomer | 0.70 | 30-189 | 93.57 | ||
Isoform 5 | 2ysz.1.A | monomer | 0.55 | 659-696 | 84.21 | ||
Isoform 6 | 7mrm.1.A | monomer | 0.72 | 30-189 | 93.57 | ||
Isoform 6 | 5tpt.1.A | monomer | 0.71 | 318-514 | 67.51 | ||
Isoform 6 | 2ysz.1.A | monomer | 0.51 | 677-714 | 84.21 | ||
Isoform 7 | 7mrm.1.A | monomer | 0.72 | 30-189 | 93.57 | ||
Isoform 7 | 5nx3.1.D | monomer | 0.69 | 289-341 | 92.86 | ||
Isoform 7 | 2ysz.1.A | monomer | 0.53 | 696-733 | 84.21 | ||
Isoform 8 | 7mrm.1.A | monomer | 0.75 | 30-189 | 93.57 | ||
Isoform 8 | 5nx3.1.D | monomer | 0.69 | 289-341 | 92.86 | ||
Isoform 8 | 2ysz.1.A | monomer | 0.53 | 714-751 | 84.21 | ||
Isoform 9 | 7mrm.1.A | monomer | 0.76 | 30-189 | 93.57 | ||
Isoform 9 | 6har.1.B | monomer | 0.70 | 294-342 | 90.57 | ||
Isoform 9 | 2ysz.1.A | monomer | 0.54 | 715-752 | 84.21 | ||
Isoform 10 | 5tpt.1.A | monomer | 0.70 | 243-439 | 67.51 | ||
Isoform 10 | 7mrm.1.B | monomer | 0.66 | 12-134 | 88.19 | ||
Isoform 11 | 7mrm.1.A | monomer | 0.75 | 25-184 | 93.53 | ||
Isoform 11 | 5nx3.1.D | monomer | 0.69 | 284-336 | 92.86 | ||
Isoform 11 | 2ysz.1.A | monomer | 0.53 | 709-746 | 84.21 | ||